Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+5.62%
-2.32%
-3.26%
+11.01%
+11.27%
Most Trending
+5.62%
-2.32%
-3.26%
+11.01%
+11.27%
Top.GainersTop.Gainers highlighting the top gainers of the day, providing timely updates and insights on the market's highest achievers.
23 Oct 2025$VTYX is the clear standout on Thursday, soaring nearly 73% after Ventyx Biosciences delivered powerful Phase 2 trial results for its inflammatory disease drug VTX3232. The data showed significant inflammation reduction, igniting excitement across the biotech sector. Volume exploded over 100 million shares, dwarfing its 2 million average. Investors cheered not just the clinical success but also renewed confidence that Ventyx pipeline may finally have commercial potential. Despite the surge pushing its RSI into overbought territory, traders remain glued to the tape, anticipating potential analyst upgrades ahead.
$GTX also grabbed the spotlight, jumping 19% after Garrett Motion posted strong Q3 results that topped both earnings and revenue estimates. The automotive tech company lifted its 2025 outlook, raised its dividend by 33%, and highlighted continued momentum in both turbocharger and zero-emission technologies. The upbeat tone from management fueled a wave of buying, as the company clean balance sheet and improving profitability painted a bullish picture heading into year-end.
$CLB moved sharply higher, climbing 28% after Core Laboratories posted its Q3 earnings report. The energy service provider impressed investors with solid results and upbeat commentary on international demand for reservoir optimization services. With oil prices stabilizing and exploration activity picking up, Core Labs’ turnaround story gained fresh credibility today, sparking strong trading interest from energy-focused funds.
$PI rallied 19% after Susquehanna reiterated its Positive rating on Impinj, a key player in RAIN RFID technology. The firm acknowledged short-term downside risk but noted robust long-term fundamentals and strong demand for inventory tracking solutions across retail and logistics. The stock surge reflected renewed confidence in growth prospects despite analyst caution, with volume nearly triple its norm.
On the losing side,
$ITGR cratered over 32% despite reporting better-than-expected Q3 numbers. Integer Holdings beat on both EPS and revenue but shocked investors by cutting its full-year guidance amid margin pressure and slowing medical device demand. The selloff was swift and heavy, with volume exceeding 13 million shares an enormous spike versus its average. Traders clearly viewed the outlook revision as a red flag, erasing months of steady gains in a single session.
For a deeper dive into each stock technical analysis, check out our full breakdown on StocksRunner.
Join StocksRunner.com for daily market updates, expert analyses, and actionable insights.
Signup now for FREE and stay ahead of the market curve!
Find out what 10,000+ subscribers already know.
Real-time insights for informed decisions.
Limited slots available, SignUp Now!
Please note that the content above should not be considered as investment advice or marketing. It does not take into account the personal data and requirements of any individual. This content is not a substitute for the reader's own judgment and should not be considered as advice or a recommendation for buying or selling any securities or financial products.
Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Real-time stock market updates
Expert stock analysis
Investment strategies
Top stock recommendations
Trading signals and opportunities
Discover what is happening right now and piece together the key data activity before the major news outlets catch on. Stay ahead of the trends
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Pro Members
